Evidence map›Paper›PMID 41040698›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Cohort profile: A community-based prospective cohort study of Alzheimer's disease and related dementias in the Democratic Republic of Congo.

Jean Ikanga, Caterina Obenauf, Saranya Sundaram Patel, Megan Schwinne, Guy Gikelekele, Emmanuel Epenge, Japhet Magolu Potshi, Topina Tomadia, Julie Kazadi, Immaculee Kavugho and 14 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Jean IkangaEmory University School of Medicine, Department of Rehabilitation Medicine, Atlanta, GA 30322, USA.ORCID 0000-0001-8754-733X
Caterina ObenaufEmory University School of Medicine, Department of Rehabilitation Medicine, Atlanta, GA 30322, USA.ORCID 0000-0002-3098-1108
Saranya Sundaram PatelEmory University School of Medicine, Department of Rehabilitation Medicine, Atlanta, GA 30322, USA.ORCID 0000-0003-1070-6421
Megan SchwinneEmory University, School of Medicine, Department of Biomedical Informatics, Atlanta, GA 30322, USA.ORCID 0009-0004-6719-8821
Guy GikelekeleUniversity of Kinshasa and Catholic University of Congo, School of Medicine, Kinshasa, Department of Psychiatry, B.P. 7463 Kinshasa I, Democratic Republic of Congo.ORCID 0009-0006-8137-7003
Emmanuel EpengeUniversity of Kinshasa, Department of Neurology, Kinshasa, B.P. 7463 Kinshasa I, Democratic Republic of Congo.ORCID 0000-0001-5233-0704
Japhet Magolu PotshiUniversity of Kinshasa, Department of Neurology, Kinshasa, B.P. 7463 Kinshasa I, Democratic Republic of Congo.ORCID 0009-0005-0581-207X
Topina TomadiaMemory Clinic of Kinshasa, Kinshasa, B.P. 7463 Kinshasa I, Democratic Republic of Congo.
Julie KazadiMemory Clinic of Kinshasa, Kinshasa, B.P. 7463 Kinshasa I, Democratic Republic of Congo.
Immaculee KavughoMemory Clinic of Kinshasa, Kinshasa, B.P. 7463 Kinshasa I, Democratic Republic of Congo.ORCID 0009-0002-7994-2115
Giovanni Luamba SantoliniMemory Clinic of Kinshasa, Kinshasa, B.P. 7463 Kinshasa I, Democratic Republic of Congo.
Francine Manyonga SabowaMemory Clinic of Kinshasa, Kinshasa, B.P. 7463 Kinshasa I, Democratic Republic of Congo.
Brenda Matungu MusewuMemory Clinic of Kinshasa, Kinshasa, B.P. 7463 Kinshasa I, Democratic Republic of Congo.
Elipsis MawisaMemory Clinic of Kinshasa, Kinshasa, B.P. 7463 Kinshasa I, Democratic Republic of Congo.
Joseph Phuati TsanguUniversity of Kinshasa, Department of anesthesiology and reanimation, B.P. 7463 Kinshasa, Democratic Republic of Congo.
Francis Muena Kondo BeyaUniversity of Kinshasa, Department of anesthesiology and reanimation, B.P. 7463 Kinshasa, Democratic Republic of Congo.
Samuel MampunzaUniversity of Kinshasa and Catholic University of Congo, School of Medicine, Kinshasa, Department of Psychiatry, B.P. 7463 Kinshasa I, Democratic Republic of Congo.ORCID 0000-0002-6875-0487
Lelo ManangaUniversity of Kinshasa, Department of Neurology, Kinshasa, B.P. 7463 Kinshasa I, Democratic Republic of Congo.ORCID 0000-0002-8398-2286
Justin BukabauUniversity of Kinshasa, Department of Internal Medicine, Kinshasa, B.P. 7463 Kinshasa I, Democratic Republic of Congo.
Charlotte E TeunissenAmsterdam University Medical Centers, Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Neurodegeneration, Amsterdam University Medical Centers, Vrije Universiteit, 1081 HV Amsterdam, the Netherlands.ORCID 0000-0002-4061-0837
Thomas KarikariUniversity of Pittsburgh, Department of Psychiatry, School of Medicine, PA, USA.ORCID 0000-0003-1422-4358
Alden L GrossDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0003-3276-2897
Julio C RojasUniversity of San Francisco, Memory and Aging Center, Weill Institute for Neurosciences, Department of Neurology, 1651 4th St, Suite 212, San Francisco, CA 94158.
Alvaro AlonsoDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.ORCID 0000-0002-2225-8323

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
The Goizueta Alzheimer's Disease Research CenterP30AG066511 · NIA · EMORY UNIVERSITY · PI Jonathan David Glass · 2020 to 2026
$29.0M
Plasma brain-derived tau: a novel Alzheimer’s disease-type neurodegeneration biomarker with potential to complete the AT(N) scheme in bloodR01AG083874 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Thomas K Karikari · 2023 to 2026
$14.5M
NCATS NIH HHS UL1 TR002378NIA NIH HHS P30 AG066511NIA NIH HHS R01 AG083874
6 · The paper itself

Abstract

introductionThe

methodsThe study is enrolling 800 adults aged ≥65 years across four diagnostic groups (cognitively unimpaired, mild cognitive impairment, Alzheimer's disease [AD], and other dementias). Recruitment occurs through community and clinical settings. Assessments include neuropsychological testing, neurological examination, social determinants, biospecimen collection, and air pollution exposure, with follow-up every two years.

resultsTo date, 506 participants have been enrolled (mean age: 73.4 years; 59.3% women). Dementia cases had greater prevalence of hypertension and other comorbidities, more neuropsychiatric symptoms, higher rates of smoking and alcohol use, lower body weight, reduced educational attainment and resilience, and increased exposure to air pollution, war, traumatic experiences, and poverty. The internal consistency of cognitive measures ranged from 0.44 to 0.91. DISCUSSION: EVCD-RDC establishes the first large-scale dementia cohort in French-speaking Sub-Saharan Africa, providing critical infrastructure and insights into risk factors for Alzheimer's disease and related dementias.

Indexed as

Alzheimer’s diseaseBiomarkersCohort studyDementiaDemocratic Republic of Congo

Identifiers

PMID41040698
PMCPMC12485996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.